Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01305460 · COMPLETED
Trial details
- NCT number
- NCT01305460
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-05
- Primary completion
- 2011-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.